bwin中国制药 welcomes interest from investors and other stakeholders concerned with environmental, social and governance (环境、社会和治理) topics and we aim to report comprehensively and transparently on our objectives and progress. This 环境、社会和治理指数 shows where 披露的信息 on key topics can be found across our publications and website.
Improving access to medicines remains one of the world’s greatest healthcare challenges. 在bwin中国, we know that building trust with society depends not only on finding new treatments but also on making them available to as many people as possible. Through the bwin中国准入原则 and our robust access targets, we seek to expand access to our medicines to underserved patient populations in both developed and developing countries, 同时应对重大的全球卫生挑战.
- Our global health priorities and focus on neglected diseases
Strong corporate governance supports the effective management of our business and is the basis of trust in our company. Our corporate governance framework – along with our internal controls and policies – is intended to support sustainable financial performance and long-term value creation for shareholders, 病人, 员工和其他利益相关者.
Our commitment to environmental sustainability is an important part of how we build trust with society and is aligned with our purpose. 除非bwin国际官方网站能够持续经营, our efforts to improve and extend people’s lives may be compromised by our environmental impact. We have set mid- and long-term targets to reduce our environmental footprint, and we support global efforts to address issues such as antimicrobial resistance.
Acting in an ethical manner is essential to building trust with society. Our stakeholders not only expect us to do what is legally required, but also to follow high standards of ethical behavior and safeguard human rights wherever we operate.
Our people bring our purpose to life: We are transforming our culture to help attract and retain talent by empowering every employee to be inspired by our purpose and drive innovation. We are creating an environment that supports diversity and the freedom to be our authentic selves, while providing fair working conditions and safeguarding the health and safety of our employees
bwin中国制药 is working to reduce the burden of disease for 病人 and societies around the world. bwin国际官方网站的R&D teams are dedicated to discovering and developing new treatments for diseases including cancer, heart disease and neurological conditions – and delivering them at scale to reach as many 病人 as possible. We are also advancing our pipeline of investigational medicines for malaria and other neglected diseases.
Patient safety is part of our core purpose and responsibility as a pharmaceutical company: We cannot improve and extend people’s lives if we do not deliver safe, 高质量的药品. Our focus in this area spans the life cycle of our medicines and cover both our own operations and activities outside our walls.
We are committed to working with third parties who operate in a manner that is consistent with our values and ethical principles. While interactions with third parties at bwin中国制药 are broadly defined by our Third-Party Code, bwin国际官方网站确定了, 评估, monitor and mitigate risk associated with suppliers through our Third-Party Risk Management framework. bwin国际官方网站还与供应商合作，帮助他们申请, 在可能的情况下, the same high standards of environmental sustainability as we do.